tiprankstipranks
Advertisement
Advertisement

ABCL Stock Latest News

AbCellera Shareholders Back Directors, Auditors, Executive Pay
Company AnnouncementsAbCellera Shareholders Back Directors, Auditors, Executive Pay
3d ago
8K
ABCL
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3d ago
JBS
ABCL
AbCellera Biologics Adds Victor Sandor to Board
PremiumCompany Announcements
AbCellera Biologics Adds Victor Sandor to Board
10d ago
8K
ABCL
AbCellera appoints Victor Sandor to board of directors
PremiumThe Fly
AbCellera appoints Victor Sandor to board of directors
10d ago
ABCL
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
26d ago
ALM
IRE
AbCellera Biologics Bets Big on 2026 Trial Catalysts
PremiumCompany AnnouncementsAbCellera Biologics Bets Big on 2026 Trial Catalysts
1M ago
ABCL
Evan Seigerman Reiterates Buy on AbCellera, Citing Strong ABCL635 Phase 1 Data and Platform Strength; $7 Price Target Maintained
Premium
Ratings
Evan Seigerman Reiterates Buy on AbCellera, Citing Strong ABCL635 Phase 1 Data and Platform Strength; $7 Price Target Maintained
1M ago
ABCL
AbCellera price target raised to $8 from $7 at Stifel
Premium
The Fly
AbCellera price target raised to $8 from $7 at Stifel
1M ago
ABCL
AbCellera Biologics options imply 9.7% move in share price post-earnings
PremiumThe Fly
AbCellera Biologics options imply 9.7% move in share price post-earnings
1M ago
ABCL
AbCellera reports Q1 EPS (14c), consensus (20c)
PremiumThe Fly
AbCellera reports Q1 EPS (14c), consensus (20c)
1M ago
ABCL
ABCL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABCL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ABCL
AbCellera initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
AbCellera initiated with an Overweight at Cantor Fitzgerald
1M ago
ABCL
AbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
PremiumRatingsAbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
2M ago
ABCL
AbCellera target is profile more attractive than Vistagen, says JonesResearch
Premium
The Fly
AbCellera target is profile more attractive than Vistagen, says JonesResearch
2M ago
ABCL
VTGN
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
Premium
Ratings
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
2M ago
ABCL
AbCellera initiated with a Buy at JonesResearch
PremiumThe Fly
AbCellera initiated with a Buy at JonesResearch
2M ago
ABCL
Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
PremiumCompany Announcements
Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
4M ago
ABCL
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
PremiumCompany Announcements
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
4M ago
ABCL
AbCellera reports FY25 EPS (49c) vs. (55c) last year
PremiumThe Fly
AbCellera reports FY25 EPS (49c) vs. (55c) last year
4M ago
ABCL
Is ABCL a Buy, Before Earnings?
PremiumPre-EarningsIs ABCL a Buy, Before Earnings?
4M ago
ABCL
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
Premium
The Fly
AbCellera doses first patients in Phase 2 portion of ABCL635 trial
5M ago
ABCL
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
Premium
The Fly
Viking Therapeutics names Neil Aubuchon as Chief Commercial Officer
5M ago
ABCL
VKTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >